Malignant Pleural Mesothelioma
MALIGNANT PLEURAL MESOTHELIOMA
... the pleural cavity (Malignant Pleural Mesothelioma; MPM) in 70 to 90 percent of cases, and the peritoneal cavity in 10 to 30 percent of ...of mesothelioma being diagnosed today are the ...
22
Malignant Pleural Mesothelioma in Parts of Japan in Relationship to Asbestos Exposure
... of construction workers. As chrysotile asbestos is widely used in Japan in a variety of applications, from construction to manufacturing, there remains a distinct possibility of increasing malignant pleural ...
5
Pemetrexed for the treatment of malignant pleural mesothelioma
... C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions ...
31
Case Report Erionite-associated malignant pleural mesothelioma in Mexico
... Abstract: Malignant mesothelioma is a highly fatal cancer of the visceral and parietal pleura most often caused by asbestos ...of malignant mesothelioma as ...associated pleural ...
11
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
... Malignant pleural mesothelioma (MPM) arises from ex- posure to asbestos fibers with a long latency period, which has been a global health problem for the past few ...
11
Malignant Pleural Mesothelioma: Case Report of fatal hemorrhagic pleural effusion
... loosely cohesive highly pleomorphic cells with few mitoses. The cells show irregular hyperchromatic nuclei, inconspicuous nucleoli and well defined eosinophillic vacuolated cytoplasm. (Figure-4) Pleural biopsy ...
6
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
... Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a short survival time arising from the mesothelial cells of the ...for malignant mesothelioma with moderate ...
13
BTS guideline for the investigation and management of malignant pleural mesothelioma
... The key aim of this guideline is to provide detailed, evidence-based guidance for the investigation of suspected malignant pleural mesothelioma (MPM) and the subsequent care and management of ...
5
The Role of Thymidylate Synthase in Pemetrexed Resistant Malignant Pleural Mesothelioma Cells
... of malignant pleural mesothelioma patients, ECyd may be extremely useful as a promising second line ...in malignant pleu- ral mesothelioma ...
8
Malignant Pleural Mesothelioma: Treatment Options and Novel Therapies
... Malignant pleural mesothelioma (MPM) is a rare primary tumor rising from the ...of mesothelioma in the US is now leveling off while its incidence is increasing in some other coun- ...tries. ...
7
Clinical staging of malignant pleural mesothelioma: current perspectives
... Abstract: Malignant pleural mesothelioma (MPM) is a disease with limited therapeutic options, the management of which is still ...International Mesothelioma Interest Group and the ...
13
Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
... Summary Insufficient evidence exists on the risk of pleural mesothelioma from non-occupational exposure to asbestos. A population-based case–control study was carried out in six areas from Italy, Spain and ...
8
Malignant Pleural Mesothelioma - Pipeline Review, H2 2014
... for Malignant Pleural Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...
8
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
... Abstract: Malignant pleural mesothelioma is a resistant form of lung cancer, and its incidence continues to rise in Europe and ...in mesothelioma, and examines in detail the key phase III ...
8
Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma
... of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11–14, 2012, Boston, ...
9
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
... a pleural tumour was in 1767 by Joseph Lieutand; however, mesothelioma was fi rst characterised as an entity by Klemperer and Rabin in 1931 ...linking mesothelioma to asbestos came from South Africa, ...
17
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
... Background: Malignant pleural mesothelioma (MPM) is a very rare and highly aggressive cancer of the pleura associated in most cases with asbestos ...
11
Malignant Pleural Mesothelioma
... Calretinin, WT1, D240, and cytokeratin 5/6 are useful immunohistochemical markers for diagnosing MPM, as are markers that typically are positive in pulmonary adenocarcinoma and negative in mesothelioma (e.g., ...
16
Modern management of malignant pleural mesothelioma
... Abstract: Malignant pleural mesothelioma (MPM) is a deadly disease that produces a significant worldwide health care burden. The majority of cases are associated with prior asbestos exposure, but ...
10
Malignant Pleural Mesothelioma at a Young Age
... Malignant mesothelioma is a tumor with poor prog- nosis that usually occurs 20-40 years after asbestos ...with malignant pleural mesothelioma who did not report any asbestos ...
5